| Literature DB >> 31184702 |
Celine A Hayden1, Chiung-Yu Hung2, Hao Zhang2, Austin Negron2, Raymond Esquerra3, Gary Ostroff4, Ambily Abraham4, Alejandro Gabriel Lopez3, Juliet Elizabeth Gonzales3, John A Howard1.
Abstract
Coccidioides is the causative agent of San Joaquin Valley fever, a fungal disease prevalent in the semiarid regions of the Americas. Efforts to develop a fungal vaccine over the last 2 decades were unsuccessful. A candidate antigen, Antigen 2 (Ag2), is notoriously difficult to express in Escherichia coli, and this study sought to accumulate the antigen at high levels in maize. Transformed maize lines accumulated recombinant Ag2 at levels >1 g/kg. Mice immunized with this antigen and challenged with live Coccidioides arthroconidia showed a reduction in the fungal load when Ag2 derived from either E. coli or maize was loaded into glucan chitin particles. A fusion of Ag2 to dendritic cell carrier peptide (DCpep) induced a T-helper type 17 response in the spleen when orally delivered, indicative of a protective immune response. The maize production platform and the glucan chitin particle adjuvant system show promise for development of a Coccidioides vaccine, but further testing is needed to fully assess the optimal method of administration.Entities:
Keywords: Coccidioides; Valley fever; bioencapsulation; glucan chitin particles; maize-produced vaccine; plant vaccine; subunit vaccine
Mesh:
Substances:
Year: 2019 PMID: 31184702 PMCID: PMC6639594 DOI: 10.1093/infdis/jiz196
Source DB: PubMed Journal: J Infect Dis ISSN: 0022-1899 Impact factor: 5.226